Monoclonal antibodies can be defined as an antibody produced by a single clone of cells; these antibodies can be produced in large quantities in the laboratory. They can also be used to carry drugs, toxins, or radioactive substances straight to cancer cells. Monoclonal antibodies have been showing promising results in the management of chronic diseases such as cancers and rheumatoid arthritis.
Asia-Pacific market for Protein A Resins is driven by factors such as high government support and increasing disposable income. Growing demand for biosimilars and increasing investments in the development of biosimilar products are also some of the key factors driving the market growth. However increasing awareness about alternate methods to purify monoclonal antibodies is hampering the Protein A Resins market. High costs associated with the Protein A resins is also a major factor restraining the market growth.
Asia-Pacific Protein A Resins Market was worth $86.34 million in 2018 and estimated to be growing at a CAGR of 9.3%, to reach $134.69 million by 2023. The market is showcasing evident potential during the forecast period owing to increasing research on monoclonal antibodies which is anticipated to drive the sales of Protein A resins.
Asia-Pacific Protein A resin market is segmented on the basis of product type, application, matrix type and end user. By product the market is further segmented Natural Protein A Resin and Recombinant Protein A Resin. Recombinant Protein A segment is estimated to be the fastest growing within this segment. On the basis of application protein A resin market is classified as Immuno precipitation and Antibody Purification. Based on Matrix type Asia-Pacific Protein A Resin market is analyzed as Glass or Silica, Agarose and Organic Polymer. Within the matrix type agarose accounts for the largest share and is estimated to maintain its strong share during the forecast period. By end user market is segmented into Biopharmaceutical Manufacturers, Clinical Research Laboratories and Academic Institutions
Based on geography Asia-Pacific Protein A resin market is analysed under various regions namely China, Japan, India, South Korea and Australia. Asia Pacific region is estimated to be the fastest growing region with a CAGR of XX% owing to large number of untapped markets and growing awareness about the developments in the market. Within Asia-Pacific Japan is the largest market for Protein A Resin accounting for a share of approximately XX% whereas India is estimated to be the fastest growing region due to lot of untapped markets.
Some of the key companies covered in the report are GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore and Expedeon Ltd.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Natural Protein A Resin
5.1.2 Recombinant Protein A Resin
5.2 By Application
5.2.1 Immunoprecipitation
5.2.2 Antibody Purification
5.3 By End Users
5.3.1 Biopharmaceutical Manufacturers
5.3.2 Clinical Research Laboratories
5.3.3 Academic Institutes
5.4 By Matrix Type
5.4.1 Glass or Silica
5.4.2 Agarose
5.4.3 Organic Polymer
6. Geographical Analysis
6.3 Asia-Pacific
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Thermo Fisher Scientific
8.3 Repligen
8.4 Tosoh Bioscience
8.5 EMD Millipore
8.6 Novasep
8.7 GenScript
8.8 Expedeon Ltd
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
